Mandatory electrocardiographic monitoring in young patients treated with psychoactive drugs

European Child and Adolescent Psychiatry

Volumn 22, Issue 9, 2013, Pages 577-579

  Rizzo, Renata ^a   Gulisano, Mariangela ^a   Calì, Paola V ^a   Di Pino, Alfredo ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b Centro Cardiologico Pediatrico del Mediterraneo   (Italy)

Author keywords

Fluoxetine; KCNQ1 gene; Obsessive compulsive disorder; Pimozide; QT long syndrome; Tourette syndrome

Indexed keywords

ARIPIPRAZOLE; FLUOXETINE; METOPROLOL; PIMOZIDE;

CASE REPORT; CHILD; DAGNOSTIC CONFIDENCE INDEX; DNA DETERMINATION; DRUG DOSE INCREASE; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY MONITORING; GENE MUTATION; GENETIC COUNSELING; GILLES DE LA TOURETTE SYNDROME; HUMAN; LETTER; LONG QT SYNDROME; MALE; NEUROPSYCHOLOGICAL TEST; OBSESSIVE COMPULSIVE DISORDER; PSYCHOLOGICAL RATING SCALE; QT PROLONGATION; QTC PROLONGATION; SCHOOL CHILD; TIC; YALE BROWN OBSESSIVE COMPULSIVE SCALE; YALE GLOBAL TIC SEVERITY SCALE;

ANTIPSYCHOTIC AGENTS; CHILD; ELECTROCARDIOGRAPHY; FLUOXETINE; HUMANS; LONG QT SYNDROME; MALE; PIMOZIDE; SEROTONIN UPTAKE INHIBITORS; TOURETTE SYNDROME;

EID: 84883489549     PISSN: 10188827     EISSN: 1435165X     Source Type: Journal    
DOI: 10.1007/s00787-013-0413-y     Document Type: Letter

References (15)

1. Kallergis EM, Goudis CA, Simantirakis EN, Kochiadakis GE, Vardas PE (2012) Mechanisms, risk factors, and management of acquired long QT syndrome: a comprehensive review. ScientificWorldJournal 2012:212178
2. Pae CU (2009) A review of the safety and tolerability of aripiprazole. Expert Opin Drug Saf 8:373-386
3. Sugiyama A, Satoh Y, Hashimoto K (2011) In vivo canine model comparison of cardiohemodynamic and electrophysiological effects of a new antipsychotic drug aripiprazole (OPC-14597) to haloperidol. Toxicol Appl Pharmacol 1:120-128
4. Nelson S, Leung JG (2013) Torsades de pointes after administration of low-dose aripiprazole. Ann Pharmacother 47(2):e11
5. Nielsen J, Graff C, Kanters JK, Toft E, Taylor D, Meyer JM (2011) Assessing QT interval prolongation and its associated risks with antipsychotics. CNS Drugs 25:473-490
6. Gulisano M, Calì PV, Cavanna AE, Eddy C, Rickards H, Rizzo R (2011) Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome. Neurol Sci 32:1213-1217
7. Pringsheim T, Marras C (2009) Pimozide for tics in Tourette's syndrome. Cochrane Database Syst Rev 15:CD006996
8. Bouvy JC, Koopmanschap MA, Shah RR, Schellekens H (2012) The cost-effectiveness of drug regulation: the example of thorough QT/QTc studies. Clin Pharmacol Ther 91:281-288
9. Labellarte MJ, Riddle MA, Crosson JE (2003) The relevance of prolonged QTc measurement to pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry 42:642-650
10. Olgun H, Sepetcigil O, Karacan M, Ceviz N (2009) An unreported side effect of risperidone in children: sinus arrest with long pauses causing syncope. Pediatr Emerg Care 25:465-466
11. Correll CU, Harris J, Figen V, Kane JM, Manu P (2011) Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control study. J Child Adolesc Psychopharmacol 21:365-368
12. Watanabe J, Suzuki Y, Fukui N et al (2012) Increased risk of antipsychotic-related QT prolongation during nighttime: a 24-hour holter electrocardiogram recording study. J Clin Psychopharmacol 32:18-22
13. Zareba W, Lin DA (2003) Antipsychotic drugs and QT interval prolongation. Psychiatry Q 74:291-306
14. Kaufman ES (2011) Arrhythmic risk in congenital long QT syndrome. J Electrocardiol 44:645-649
15. Moss AJ (2000) Long QT syndromes. Curr Treat Options in Cardiovasc Med 2:317-322